Risk Factors for Failure in Double-Plate Tube Surgery for Refractory Glaucoma: 25 Years Surgical Experience

References

• Gedde SJ, Schiffman JC, Feuer WJ, et al. Treatment outcomes in the tube versus trabeculectomy (TVT) study after five years of follow-up. Am J Ophthalmol. 2012;153(5):789–803.e2. doi:10.1016/j.ajo.2011.10.026
   PubMed Web of Science ®Google Scholar
• Vinod K, Gedde SJ, Feuer WJ, et al. Practice preferences for glaucoma surgery: a survey of the American glaucoma society. J Glaucoma. 2017;26(8):687–693. doi:10.1097/IJG.0000000000000720
   PubMed Web of Science ®Google Scholar
• Tseng VL, Coleman AL, Chang MY, Caprioli J. Aqueous shunts for glaucoma. Cochrane Database Syst Rev. 2017;7. doi:10.1002/14651858.CD004918.pub3
   Web of Science ®Google Scholar
• Gedde SJ, Feuer WJ, Shi W, et al. Treatment outcomes in the primary tube versus Trabeculectomy Study after 1 year of follow-up. Ophthalmology. 2018;125(5):650–663. doi:10.1016/j.ophtha.2018.02.003
   PubMed Web of Science ®Google Scholar
• Molteno ACB, Suter AJ, Fenwick M, Bevin TH, Dempster AG. Otago glaucoma surgery outcome study: cytology and immunohistochemical staining of bleb capsules around molteno implants. Invest Ophthalmol Vis Sci. 2006;47(5):1975–1981. doi:10.1167/iovs.05-0988
   Web of Science ®Google Scholar
• Molteno ACB, Bevin TH, Dempster AG, Sarris M, McCluskey P. Otago glaucoma surgery outcome study: cytology and immunohistochemistry of trabeculectomy blebs. Invest Ophthalmol Vis Sci. 2013;54(7):4991–4999. doi:10.1167/iovs.12-11553
   Web of Science ®Google Scholar
• Chen CW. Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin-c. Trans Asia Pac Acad Ophthalmol. 1983;9:172–177.
   Google Scholar
• Cantor L, Burgoyne J, Sanders S, Bhavnani V, Hoop J, Brizendine E. The effect of mitomycin C on molteno implant surgery: a 1-year randomized, masked, prospective study. J Glaucoma. 1998;7(4):240–246. doi:10.1097/00061198-199808000-00005
   PubMed Web of Science ®Google Scholar
• Leng F, Liu P, Li H, Zhang J. Long-term topical antiglaucoma medications cause enhanced Tenon’s capsule fibroblast proliferation and abnormal TGF-β and MMP expressions: potential effects on glaucoma filtering surgery. Curr Eye Res. 2011;36(4):301–309. doi:10.3109/02713683.2010.547648
   PubMed Web of Science ®Google Scholar
• Bettin P, Khaw PT, eds. Glaucoma Surgery. 2nd. Vol. 59. Karger; 2017. AG2017ISSN0250-3751
   Google Scholar
• Broadway DC, Iester M, Schulzer M, Douglas GR. Survival analysis for success of molteno tube implants. Br J Ophthalmol. 2001;85(6):689–695. doi:10.1136/bjo.85.6.689
   Web of Science ®Google Scholar
• Thompson AM, Molteno ACB, Bevin TH, Herbison P. Otago Glaucoma Surgery Outcome Study. Comparative results for the 175-mm2 molteno3 and double-plate molteno implants. JAMA Ophthalmol. 2013;131(2):155–159. doi:10.1097/00132578-200004000-00014
   Web of Science ®Google Scholar
• Mills RP, Reynolds A, Emond MJ, Barlow WE, Leen MM. Long-term survival of molteno glaucoma drainage devices. Ophthalmology. 1996;103(2):299–305. doi:10.1016/S0161-6420(96)30700-8
   PubMed Web of Science ®Google Scholar
• Every SG, Molteno ACB, Bevin TH, Herbison P. Long-term results of molteno implant insertion in cases of neovascular glaucoma. Arch Ophthalmol. 2006;124:355–360. doi:10.1001/archopht.124.3.355
   PubMedGoogle Scholar
• Fuller JR, Bevin TH, Molteno ACB. Long-term follow-up of traumatic glaucoma treated with molteno implants. Ophthalmology. 2001;108(10):1796–1800. doi:10.1016/S0161-6420(01)00714-X
   Web of Science ®Google Scholar
• Ohira S, Inoue T, Iwao K, Takahashi E, Tanihara H, Acott TS. Factors influencing aqueous proinflammatory cytokines and growth factors in uveitic glaucoma. PLoS One. 2016;11(1):1–13. doi:10.1371/journal.pone.0147080
   Web of Science ®Google Scholar
• Chono I, Miyazaki D, Miyake H, Komatsu N, Ehara F. High interleukin-8 level in aqueous humor is associated with poor prognosis in eyes with open angle glaucoma and neovascular glaucoma. Sci Rep. 2018;8(1):1. doi:10.1038/s41598-018-32725-3
   Web of Science ®Google Scholar
• Molteno ACB, Sayawat N, Herbison P. Otago Glaucoma Surgery Outcome Study. Long-term Results of uveitis with secondary glaucoma drained by molteno implants. Ophthalmology. 2001;108(3):605–613. doi:10.1016/S0161-6420(00)00594-7
   Web of Science ®Google Scholar
• Ramdas WD, Pals J, Rothova A, Wolfs RCW. Efficacy of glaucoma drainage devices in uveitic glaucoma and a meta-analysis of the literature. Graefe’s Arch Clin Exp Ophthalmol. 2019;257:143–151. doi:10.1007/s00417-018-4156-9
   Web of Science ®Google Scholar
• Goldberg I. Management of uncontrolled glaucoma with the molteno system. Aust N Z J Ophthalmol. 1987;15(2):97–107. doi:10.1111/j.1442-9071.1987.tb00053.x
   Google Scholar
• Nesher R, Sherwood M, Kass M, Hines J, Kolker A. Molteno implants in children. J Glaucoma. 1992;1(4):228–232. doi:10.1097/00061198-199201040-00003
   PubMedGoogle Scholar
• Ah-Chan JJ, Molteno ACB, Bevin TH, Herbison P. Otago Glaucoma Surgery Outcome Study. Follow-up of young patients who underwent molteno implant surgery. Ophthalmology. 2005;112(12):2137–2142. doi:10.1016/j.ophtha.2005.07.011
   PubMed Web of Science ®Google Scholar
• Freedman J, Iserovich P. Pro-inflammatory cytokines in glaucomatous aqueous and encysted molteno implant blebs and their relationship to pressure. Invest Ophthalmol Vis Sci. 2013;54(7):4851–4855. doi:10.1167/iovs.13-12274
   PubMed Web of Science ®Google Scholar
• Richter CU, Shingleton BJ, Bellows AR, Hutchinson BT, O’Connor T, Brill I. The development of encapsulated filtering blebs. Ophthalmology. 1988;95(9):1163–1168. doi:10.1016/S0161-6420(88)33041-1
   Web of Science ®Google Scholar
• Arthur S, Cantor LB. Update on the role of alpha-agonists in glaucoma management. Exp Eye Res. 2011;93(3):271–283. doi:10.1016/j.exer.2011.04.002
   PubMed Web of Science ®Google Scholar
• Minckler D, Vedula S, Li T, Mathew M, Ayyala R, Francis B. Aqueous shunts for glaucoma (review). Cochrane Database Syst Rev. 2006;2. doi:10.1002/14651858.CD004918.pub2
   Web of Science ®Google Scholar
• Smith MF, Doyle JW, Sherwood MB. Comparison of the baerveldt glaucoma implant with the double-plate molteno drainage implant. Arch Ophthalmol. 1995;113(4):444–447. doi:10.1001/archopht.1995.01100040060027
   Google Scholar
• Christakis PG, Zhang D, Budenz DL, Barton K, Tsai JC, Ahmed IIK. Five-year pooled data analysis of the Ahmed Baerveldt Comparison Study and the Ahmed Versus Baerveldt Study. Am J Ophthalmol. 2017;176:118–126. doi:10.1016/j.ajo.2017.01.003
   PubMed Web of Science ®Google Scholar
• Choritz L, Koynov K, Renieri G, Barton K, Pfeiffer N, Thieme H. Surface topographies of glaucoma drainage devices and their influence on human tenon fibroblast adhesion. Invest Ophthalmol Vis Sci. 2010;51:4047–4053. doi:10.1167/iovs.09-4759
   Web of Science ®Google Scholar
• Duch S. El tratamiento del glaucoma refractario con los distintos implantes de drenaje: modelo experimental [Thesis]. 1995. C:1995-96–BDD:09504118F/ETS
   Google Scholar
• Molteno ACB, Thompson AM, Bevin TH, Dempster AG. Otago glaucoma surgery outcome study: tissue matrix breakdown by apoptotic cells in capsules surrounding molteno implants. Invest Ophthalmol Vis Sci. 2009;50(3):1187–1197. doi:10.1167/iovs.07-1424
   Web of Science ®Google Scholar
• Molteno ACB, Fucik M, Dempster AG, Bevin TH. Otago Glaucoma Surgery Outcome Study: factors controlling capsule fibrosis around molteno implants with histopathological correlation. Ophthalmology. 2003;110(11):2198–2206. doi:10.1016/S0161-6420(03)00803-0
   Web of Science ®Google Scholar
• Law SK, Kornmann HL, Giaconi JA, Kwong A, Tran E, Caprioli J. Early aqueous suppressant therapy on hypertensive phase following glaucoma drainage device procedure: a randomized prospective trial. J Glaucoma. 2016;25(3):248–257. doi:10.1097/IJG.0000000000000131
   Web of Science ®Google Scholar
• Ayyala RS, Zurakowski D, Monshizadeh R, et al. Comparison of double-plate molteno and ahmed glaucoma valve in patients with advanced uncontrolled glaucoma. Ophthalmic Surg Lasers. 2002;33(2):94–101.
   Google Scholar
• Ayyala RS, Zurakowski D, Smith JA, et al. A clinical study of the ahmed glaucoma valve implant in advanced glaucoma. Ophthalmology. 1998;105(10):1968–1976. doi:10.1016/S0161-6420(98)91049-1
   PubMed Web of Science ®Google Scholar
• Koh SWM, Coll TJ, Rose L, Matsumoto Y, Higginbotham EJ. Antiglaucoma eye drop pulses - increased interleukin-6 secretion by Tenon’s capsule fibroblast cultures. J Glaucoma. 2004;13(3):200–209. doi:10.1097/00061198-200406000-00005
   Web of Science ®Google Scholar
• Weiner A, Cohn AD, Balasubramaniam M, Weiner AJ. Glaucoma tube shunt implantation through the ciliary sulcus in pseudophakic eyes with high risk of corneal decompensation. J Glaucoma. 2010;19(6):405–411. doi:10.1097/IJG.0b013e3181bdb52d
   Web of Science ®Google Scholar
• Luke SK. Complications of peripheral iridectomy. Can J Ophthalmol. 1969;4(4):346–351.
   Google Scholar
• Aketa N, Yamaguchi T, Suzuki T, et al. Iris damage is associated with elevated cytokine levels in aqueous humor. Invest Ophthalmol Vis Sci. 2017;58(6):BIO42–BIO51. doi:10.1167/iovs.17-21421
   PubMed Web of Science ®Google Scholar
• Molteno ACB, Straughan JL, Ancker E. Control of bleb fibrosis after glaucoma surgery by anti-inflammatory agents. S Afr Med J. 1976;50(23):881–885.
   Web of Science ®Google Scholar
• Fargione RA, Tansuebchueasai N, Lee R, Tania Tai TY. Etiology and management of the hypertensive phase in glaucoma drainage-device surgery. Surv Ophthalmol. 2019;64(2):217–224. doi:10.1016/j.survophthal.2018.10.008
   Web of Science ®Google Scholar
• Pakravan M, Rad SS, Yazdani S, Ghahari E, Yaseri M. Effect of early treatment with aqueous suppressants on ahmed glaucoma valve implantation outcomes. Ophthalmology. 2014;121:1693–1698. doi:10.1016/j.ophtha.2014.03.014
   Web of Science ®Google Scholar
• Ellingham RB, Morgan WH, Westlake W, House PH. Mitomycin C eliminates the short-term intraocular pressure rise found following molteno tube implantation. Clin Exp Ophthalmol. 2003;31(3):191–198. doi:10.1046/j.1442-9071.2003.00644.x
   Web of Science ®Google Scholar
• Nouri-Mahdavi K, Caprioli J. Evaluation of the hypertensive phase after insertion of the ahmed glaucoma valve. Am J Ophthalmol. 2003;136(6):1001–1008. doi:10.1016/S0002-9394(03)00630-5
   PubMed Web of Science ®Google Scholar